drugset

drugset / Trial / NCT04075409

A Study to Test the Safety, and Tolerability of Padsevonil in Healthy Male Japanese Study Participants

NCT04075409 ↗

Phase 1 Completed 39 enrolled UCB Biopharma S.P.R.L.

Non-randomizedParallel-groupOpen-labelBasic science

Summary

The purpose of the study is to investigate the pharmacokinetics (PK) of padesevonil in CYP2C19 genotyped healthy male Japanese study participants.

Timeline

Start: 2019-09-30
Primary completion: 2019-12-27
Completion: 2019-12-27

Publications

Chanteux H, MacPherson M, Kramer H, Otoul C, Okagaki T, Rospo C, De Bruyn S, Watling M, Bani M, Sciberras D. Overview of preclinical and clinical studies investigating pharmacokinetics and drug-drug interactions of padsevonil. Expert Opin Drug Metab Toxicol. 2024 Aug;20(8):841-855. doi: 10.1080/17425255.2024.2373108. Epub 2024 Jul 9.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Padsevonil	Small molecule	—	—

Indications

No indication recorded.